DELCATH SYSTEMS, INC. (DCTH)

Latest Insider Confidence Score

2026Q1

51.3
Bullish

Company insider confidence (by quarter)

2011Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Aharon Gil Director 3,413,468 May 9, 2025
Salamon Steven A J Director 3,413,468 May 9, 2025
Rosalind Advisors, Inc. Director 3,413,468 May 9, 2025
Ladd Robert Director 631,294 Jun 19, 2012
Michel Gerard J CEO 330,834 Nov 13, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 6, 2026 Mar 6, 2026 Pennell Sandra CFO Buy 90.0 +5,533 7.74% ✗ $50K
Mar 2, 2026 Mar 3, 2026 MICHEL GERARD J CEO Buy 87.5 +11,200 3.39% ✗ $100.3K
Feb 17, 2026 Feb 18, 2026 Hoffman David L. GEN'L COUNSEL, CCO & SECY Neutral 52.5 - 0.00% ✗ -
Feb 17, 2026 Feb 18, 2026 Muir Kevin GM INTERVENTIONAL ONCOLOGY Neutral 52.5 - 0.00% ✗ -
Feb 17, 2026 Feb 18, 2026 Pennell Sandra CFO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2026 Feb 18, 2026 Vukovic Vojo CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 17, 2026 Feb 18, 2026 Rook Martha S. COO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2026 Feb 18, 2026 MICHEL GERARD J CEO Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Nov 25, 2025 Sylvester John Richard Director Buy 91.3 +4,386 41.57% ✗ $39K
Nov 11, 2025 Nov 13, 2025 MICHEL GERARD J CEO Buy 87.5 +11,500 3.60% ✗ $98K
Jun 12, 2025 Jun 13, 2025 Vukovic Vojo CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
May 15, 2025 May 19, 2025 Sylvester John Richard Director Neutral 52.5 - 0.00% ✗ -
May 15, 2025 May 19, 2025 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
May 15, 2025 May 19, 2025 CZEREPAK ELIZABETH Director Neutral 52.5 - 0.00% ✗ -
May 15, 2025 May 19, 2025 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
May 15, 2025 May 19, 2025 Martell Bridget A Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 9, 2025 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 9, 2025 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 9, 2025 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 7, 2025 Hoffman David L. GEN'L COUNSEL, CCO & SECY Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 7, 2025 Pennell Sandra CFO Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 7, 2025 Muir Kevin GM INTERVENTIONAL ONCOLOGY Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 7, 2025 Rook Martha S. COO Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 7, 2025 Vukovic Vojo CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 7, 2025 MICHEL GERARD J CEO Neutral 52.5 - 0.00% ✗ -
Dec 24, 2024 Dec 27, 2024 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
Dec 24, 2024 Dec 26, 2024 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
Dec 24, 2024 Dec 26, 2024 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Oct 30, 2024 Nov 1, 2024 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
Oct 30, 2024 Nov 1, 2024 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
Oct 30, 2024 Nov 1, 2024 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Oct 22, 2024 Oct 23, 2024 MICHEL GERARD J CEO Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 28, 2024 CZEREPAK ELIZABETH Director Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 28, 2024 Sylvester John Richard Director Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 28, 2024 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 28, 2024 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 28, 2024 Martell Bridget A Director Neutral 52.5 - 0.00% ✗ -
May 28, 2024 Martell Bridget A Director Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 28, 2024 STOLL ROGER G PHD Director Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 May 16, 2024 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 May 16, 2024 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 May 16, 2024 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 May 16, 2024 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 May 16, 2024 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 May 16, 2024 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Mar 19, 2024 Mar 20, 2024 Aharon Gil Director Buy 87.5 +26,882 2.58% ✗ $100K
Mar 19, 2024 Mar 20, 2024 SALAMON STEVEN A J Director Buy 82.5 +26,882 2.46% ✗ $100K
Mar 19, 2024 Mar 20, 2024 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Mar 18, 2024 Mar 20, 2024 Rook Martha S. COO Neutral 52.5 - 0.00% ✗ -
Mar 20, 2024 Rook Martha S. COO Neutral 52.5 - 0.00% ✗ -
Mar 19, 2024 Mar 19, 2024 Vukovic Vojo CHIEF MEDICAL OFFICER Neutral 90.0 +26,882 26.88% ✗ -
Mar 19, 2024 Mar 19, 2024 MICHEL GERARD J CEO Neutral 90.0 +40,323 15.37% ✗ -
Mar 19, 2024 Mar 19, 2024 Pennell Sandra SVP OF FINANCE, PFO AND PAO Neutral 90.0 +26,881 78.67% ✗ -
Mar 19, 2024 Mar 19, 2024 Muir Kevin GM INTERVENTIONAL ONCOLOGY Neutral 90.0 +13,441 261.45% ✗ -
Mar 19, 2024 Mar 19, 2024 Hoffman David L. GEN'L COUNSEL, CCO & SECY Neutral 90.0 +20,161 37.22% ✗ -
Feb 8, 2023 Feb 20, 2024 Dias Anthony VP FINANCE Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Vukovic Vojo CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 MICHEL GERARD J CEO Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Muir Kevin VP COMMERCIAL OPERATIONS Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Pennell Sandra SVP OF FINANCE, PFO AND PAO Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Hoffman David L. GEN'L COUNSEL, CCO & SECY Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Jan 26, 2024 Muir Kevin VP COMMERCIAL OPERATIONS Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Jan 26, 2024 Hoffman David L. GEN'L COUNSEL, CCO & SECY Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Jan 26, 2024 Purpura John COO Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Jan 26, 2024 John Johnny SVP CLINICAL DEV & MED AFFAIRS Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Jan 26, 2024 MICHEL GERARD J CEO Neutral 52.5 - 0.00% ✗ -
Dec 12, 2023 Dec 14, 2023 Vukovic Vojo Chief Medical Officer Buy 95.0 +40,000 66.67% ✗ $120K
Dec 8, 2023 Dec 11, 2023 MICHEL GERARD J CEO Buy 95.0 +34,000 14.89% ✗ $100K
Nov 17, 2023 Nov 21, 2023 Rosalind Advisors, Inc. Director Buy 95.0 +100,000 10.65% ✗ $240.4K
Nov 17, 2023 Nov 21, 2023 Pennell Sandra SVP of Finance, PFO and PAO Buy 95.0 +30,000 100.00% ✗ $72.9K
Nov 16, 2023 Nov 20, 2023 Vukovic Vojo Chief Medical Officer Buy 95.0 +60,000 100.00% ✗ $148.8K
Nov 16, 2023 Nov 20, 2023 Hoffman David L. Officer Buy 95.0 +40,000 100.00% ✗ $99.2K
Oct 13, 2023 Oct 17, 2023 Purpura John COO Buy 91.3 +14,505 53.68% ✗ $49.9K
Aug 21, 2023 Aug 23, 2023 Sylvester John Richard Director Buy 95.0 +10,550 100.00% ✗ $50.6K
Aug 21, 2023 Aug 22, 2023 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2023 Aug 21, 2023 MICHEL GERARD J CEO Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 22, 2023 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 22, 2023 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 22, 2023 Sylvester John Richard Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2023 Vukovic Vojo Officer Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 22, 2023 Purpura John COO Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 22, 2023 Muir Kevin Officer Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 21, 2023 Pennell Sandra Officer Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 21, 2023 STOLL ROGER G PHD Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 21, 2023 Hoffman David L. Officer Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 21, 2023 MICHEL GERARD J CEO Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 21, 2023 CZEREPAK ELIZABETH Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 21, 2023 John Johnny Officer Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Pennell Sandra Officer Neutral 52.5 - 0.00% ✗ -
Apr 18, 2023 Apr 20, 2023 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Mar 29, 2023 Mar 30, 2023 MICHEL GERARD J CEO Buy 95.0 +19,646 11.06% ✗ $95.1K
Dec 14, 2022 Dec 16, 2022 Rosalind Advisors, Inc. Director Buy 87.5 +15,215 3.43% ✗ $55K
Dec 14, 2022 Dec 16, 2022 SALAMON STEVEN A J Director Buy 87.5 +15,215 3.46% ✗ $55K
Dec 13, 2022 Dec 14, 2022 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -
Dec 13, 2022 Dec 14, 2022 Rosalind Advisors, Inc. Director Neutral 52.5 - 0.00% ✗ -
Dec 13, 2022 Dec 14, 2022 SALAMON STEVEN A J Director Neutral 52.5 - 0.00% ✗ -
Dec 13, 2022 Dec 14, 2022 MICHEL GERARD J CEO Buy 95.0 +51,725 41.10% ✗ $150K
Aug 15, 2022 John Johnny Officer Neutral 52.5 - 0.00% ✗ -
Jul 20, 2022 Jul 21, 2022 MICHEL GERARD J CEO Buy 95.0 +62,814 99.63% ✗ $250K
Jul 18, 2022 Jul 20, 2022 Aharon Gil Director Neutral 52.5 - 0.00% ✗ -